in patients in the high risk groupscan be preventedin patients in the high risk groups
in the demonstration of intrahepatic abscesses , the vermiform appendix , and the skinresultingin the demonstration of intrahepatic abscesses , the vermiform appendix , and the skin
portal hypertensioncausingportal hypertension
an intense inflammationcausesan intense inflammation
the adverse side effects(passive) caused bythe adverse side effects
mechanical compromise ( such as due to alcohol cirrhosiscausingmechanical compromise ( such as due to alcohol cirrhosis
pylephlebitis from appendicitis or diverticulitiscausingpylephlebitis from appendicitis or diverticulitis
in ischemic hepatic necrosisresultingin ischemic hepatic necrosis
in an enterohepatic biking which might delay the action of drugresultingin an enterohepatic biking which might delay the action of drug
to an enterohepatic cycling which can prolong the action of drug e. Tetracylines which are excreted by biliary tractleadingto an enterohepatic cycling which can prolong the action of drug e. Tetracylines which are excreted by biliary tract